Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Polarityte Inc
(NQ:
PTE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 15, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Polarityte Inc
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Friday's After-Market Session
May 13, 2022
Gainers Trevena (NASDAQ:TRVN) shares moved upwards by 13.3% to $0.23 during Friday's after-market session. The market value of their outstanding shares is at $38.0 million. As per the news, the Q1...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 13, 2022
Via
Benzinga
Why Is SoFi (SOFI) Stock Up 20% Today?
May 13, 2022
SoFi (SOFI) stock is riding higher on Friday as the company's shares are recovering from a fall earlier this week and we know why!
Via
InvestorPlace
PTE Stock Soars 70% Following PolarityTE’s New FDA Designation
May 13, 2022
PolarityTE (PTE) stock is rocketing higher on Friday thanks to positive news from the U.S. Food and Drug Administration (FDA).
Via
InvestorPlace
Earnings Outlook For PolarityTE
May 13, 2022
PolarityTE (NASDAQ:PTE) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that PolarityTE will...
Via
Benzinga
Recap: PolarityTE Q4 Earnings
March 30, 2022
PolarityTE (NASDAQ:PTE) reported its Q4 earnings results on Wednesday, March 30, 2022 at 07:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
PolarityTE Shares Jump After FDA Regenerative Medicine Advanced Therapy Designation (RMAT) for SkinTE
May 13, 2022
The U.S. Food and Drug Administration (FDA) has granted a Regenerative Medicine Advanced Therapy (RMAT) designation to PolarityTE’s (NASDAQ: PTE) SkinTE under the its open investigational new drug...
Via
Benzinga
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
May 13, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 13, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 13, 2022
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
April 13, 2022
Rise and shine, trader! Join me today as we break down all the news behind the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
Why Is PolarityTE Stock Up 85% Today?
April 12, 2022
PolarityTE Inc (NASDAQ: PTE) shares are surging Tuesday as traders circle bullish commentary from a popular trader in the "FinTwit" community.
Via
Benzinga
Biotech Stocks News: What’s Going on With LIXT, PTE, QLGN and ATNM Stocks Today?
April 12, 2022
Biotech stocks are up today amid an influx of positive news. Here's what investors need to know as these small companies skyrocket.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 12, 2022
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 12, 2022
Good morning! It's time for another dive into the market this morning with a look at the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
March 31, 2022
On Thursday, 92 companies hit new 52-week lows. Areas of Interest About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week...
Via
Benzinga
Looking Into PolarityTE's Return On Capital Employed
March 31, 2022
Benzinga Pro data, PolarityTE (NASDAQ:PTE) reported Q4 sales of $1.04 million. Earnings fell to a loss of $8.57 million, resulting in a 739.18% decrease from last quarter.
Via
Benzinga
Earnings Scheduled For March 30, 2022
March 30, 2022
Companies Reporting Before The Bell • Orgenesis (NASDAQ:ORGS) is likely to report earnings for its fourth quarter. • RumbleON (NASDAQ:RMBL) is estimated to report earnings for its Fiscal Year 2021.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 29, 2022
On Tuesday, 81 stocks hit new 52-week lows. Noteworthy Points From Today's 52-Week Lows: Grupo Aval Acciones (NYSE:AVAL) was the biggest company by market cap to set a...
Via
Benzinga
Earnings Preview: PolarityTE
March 29, 2022
PolarityTE (NASDAQ:PTE) is set to give its latest quarterly earnings report on Wednesday, 2022-03-30. Here's what investors need to know before the announcement. Analysts estimate that PolarityTE will...
Via
Benzinga
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
March 27, 2022
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
March 23, 2022
Rise and shine, trader! We're starting off the day with a breakdown of the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 21, 2022
Gainers Corbus Pharmaceuticals (NASDAQ:CRBP) shares increased by 20.3% to $0.4 during Monday's pre-market session. The market value of their outstanding shares is at $49.7 million.
Via
Benzinga
PolarityTE Q4 2021 Earnings Conference Call On March 30, 2022 At 08:30 AM ET
March 17, 2022
PolarityTE (NASDAQ:PTE) will host a conference call at 08:30 AM ET on March 30, 2022, to discuss Q4 2021 earnings results. How to Attend PolarityTE (PTE) Conference Call Follow...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 16, 2022
Gainers Sonnet BioTherapeutics (NASDAQ:SONN) stock rose 85.6% to $0.51 during Wednesday's pre-market session. The company's market cap stands at $30.8 million....
Via
Benzinga
PolarityTE's SkinTE Meets Primary, Secondary Goals In Venous Leg Ulcers Trial
February 22, 2022
PolarityTE Inc (NASDAQ: PTE) has announced results from a multi-center randomized controlled trial evaluating SkinTE for Venous Leg Ulcers (VLU). There were twenty-...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 22, 2022
Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 15.5% to $3.95 during Tuesday's pre-market session. The company's market cap stands at $213.3 million....
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 07, 2022
Gainers Agile Therapeutics (NASDAQ:AGRX) ...
Via
Benzinga
PolarityTE, Inc. (NASDAQ:PTE) Long Term Investor Alert: Investigation over Possible Wrongdoing
January 26, 2022
San Diego, CA -- (SBWIRE) -- 01/26/2022 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of PolarityTE, Inc..
Via
SBWire
12 Health Care Stocks Moving In Friday's After-Market Session
January 21, 2022
Gainers Mustang Bio (NASDAQ:MBIO) shares ...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.